Department of Surgery, Tufts University School of Medicine, Boston, MA, USA.
Department of Surgery, The Ohio State University Wexner Medical Center, 395 W. 12th Ave., Suite 670, Columbus, OH, USA.
J Gastrointest Surg. 2022 Sep;26(9):1998-2007. doi: 10.1007/s11605-022-05382-1. Epub 2022 Jun 15.
Hepatic hemangiomas (HHs) are benign liver lesions often discovered incidentally on imaging for various unrelated pathologies. We herein review the etiology, classification, diagnostic imaging, and management of HHs.
A comprehensive systematic review was performed utilizing MEDLINE/PubMed and Web of Science databases, with the end of search date being March 1, 2022, regarding HH diagnosis, imaging, and management.
HHs can be broadly classified as capillary hemangiomas or cavernous hemangiomas. While the exact pathophysiology related to the development of HHs remains largely unknown, hormone exposure has been postulated to cause HH growth. HHs appear homogenously hyperechoic on US with distinct margins and posterior acoustic enhancement. While cavernous hemangiomas appear as well-defined hypodense lesions on pre-contrast CT images with the same density as the vasculature, one of the most reliable imaging features for diagnosing cavernous hemangiomas is high signal intensity on T2 weighted images. While most HHs are asymptomatic, some patients can present with pain or compressive symptoms with bleeding/rupture being very rare. Kasabach-Merritt syndrome is a rare but life-threatening condition associated with thrombocytopenia and microangiopathic hemolytic anemia. When HHs are symptomatic or in the setting of Kasabach Merritt syndrome, surgery is indicated. Enucleation is an attractive surgical option for HH as it spares normal liver tissue. Most patients experience symptom relief following surgical resection.
HHs are very common benign liver lesions. High-quality imaging is imperative to distinguish HHs from other liver lesions. Surgery is generally reserved for patients who present with symptoms such as pain, obstruction, or rarely Kasabach-Merritt syndrome. Surgery can involve either formal resection or, in most instances, simple enucleation. Patients generally have good outcomes following surgery with resolution of their symptoms.
肝血管瘤(HHs)是一种常见的良性肝脏病变,通常在因其他各种无关疾病进行影像学检查时偶然发现。本文综述了 HHs 的病因、分类、诊断影像学和治疗方法。
我们使用 MEDLINE/PubMed 和 Web of Science 数据库进行了全面的系统综述,检索截至 2022 年 3 月 1 日,主要涉及 HHs 的诊断、影像学和治疗。
HHs 可大致分为毛细血管型血管瘤或海绵状血管瘤。虽然导致 HHs 发展的确切病理生理学机制尚不完全清楚,但激素暴露被认为会导致 HH 生长。HHs 在 US 上表现为均匀高回声,边界清晰,后方回声增强。虽然海绵状血管瘤在 CT 平扫图像上表现为边界清晰的低密度病变,密度与血管相同,但诊断海绵状血管瘤最可靠的影像学特征之一是 T2 加权图像上的高信号强度。虽然大多数 HHs 无症状,但有些患者可能会出现疼痛或压迫症状,出血/破裂非常罕见。Kasabach-Merritt 综合征是一种罕见但危及生命的疾病,与血小板减少症和微血管溶血性贫血有关。当 HHs 出现症状或伴有 Kasabach-Merritt 综合征时,需要手术治疗。HH 手术切除时,肝叶切除术是一种有吸引力的手术选择,因为它可以保留正常的肝组织。大多数患者在手术后症状缓解。
HHs 是非常常见的良性肝脏病变。高质量的影像学检查对于将 HHs 与其他肝脏病变区分开来至关重要。手术一般保留给有症状(如疼痛、梗阻,或罕见的 Kasabach-Merritt 综合征)的患者。手术可以包括正式的切除或,在大多数情况下,简单的肝叶切除术。患者术后症状缓解,预后良好。